Risk for Hodgkin Lymphoma Increased With Allergic Disease, Eczema
Associations attenuated but remained significant after adjustment for steroid use.
Lymphoma
Reduced‐Intensity Conditioning May Improve Survival in Relapsed/Refractory Anaplastic Large Cell Lymphoma
Overall survival at 5 years was 100% with the reduced-intensity conditioning regimen compared with 48.5% with the myeloablative conditioning regimen.
Older Patients With Follicular Lymphoma Benefit From Appropriate Therapy
For older patients with follicular lymphoma, receipt of appropriate therapy for this disease was associated with a significant gain in overall survival.
Real-World Outcomes With Ibrutinib in Waldenström Macroglobulinemia
A study of real-world patients with Waldenström macroglobulinemia revealed that ibrutinib monotherapy was linked to efficacy — but also toxicity.
Health-Related Quality of Life Unchanged With Lenalidomide Maintenance for DLBCL
Progression-free survival was superior with lenalidomide compared with placebo, while health-related quality of life was similar and did not change during the study.
Immunoglobulin Replacement May Benefit Some Patients Receiving CAR-T Therapy
CAR-T therapy can sometimes lead to immune system dysfunction, subsequent hypogammaglobulinemia, and the need for antibody replacement therapy.
High Use of Oncology Nurse Navigators Showed Similar Clinical Outcomes for White, Nonwhite Patients with DLBCL
Although previous population-based studies have shown worse clinical outcomes for minority patients with DLBCL compared with white patients, this study reported no differences in PFS and OS were seen between the 2 groups.
Concomitant Diseases May Significantly Affect Outcomes in Patients With Mantle Cell Lymphoma
Severe comorbidities were found to be associated with increased all-cause and lymphoma-specific mortality compared with patients without comorbidities.
Treatment Characteristics and Outcomes for Patients With Rare Forms of T-Cell Lymphoma
Researchers characterized outcomes for enteropathy-associated T-cell lymphoma, hepatosplenic T-cell lymphoma, and peripheral gamma delta T-cell lymphoma.
CAR-T Therapy May Be Associated With Decreased Utilization of Health Care Resources in Older, “Real-World” Patients With NHL
In this study, claims data from CMS were used to estimate health care utilization of patients with DLCBL before and after CAR-T therapy.
- Loading...
Loading...
Next post in ASH 2019
Loading... 
Loading...